Human T follicular helper (Tfh) cells and disease

Immunology and Cell Biology

Volumn 92, Issue 1, 2014, Pages 64-71

  Ma, Cindy S ^a,b   Deenick, Elissa K ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Autoimmunity; Cancer; Human; Human Tfh cells; Immunodeficiency

Indexed keywords

INTERLEUKIN 12 RECEPTOR BETA1;

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOSOMAL DOMINANT INHERITANCE; BACTERIAL INFECTION; BREAST CANCER; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE PREDISPOSITION; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE MUTATION; GRAVES DISEASE; HASHIMOTO DISEASE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPER IGE SYNDROME; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNE RESPONSE; JUVENILE DERMATOMYOSITIS; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYCOBACTERIAL DISEASE; MYCOSIS FUNGOIDES; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; REVIEW; RHEUMATOID ARTHRITIS; SEZARY SYNDROME; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T FOLLICULAR HELPER CELL; TUMOR GROWTH; VACCINATION; X CHROMOSOME LINKED DISORDER;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84891766847     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.55     Document Type: Review

References (95)

1. Deenick EK, Ma CS, Brink R, Tangye SG. Regulation of T follicular helper cell formation and function by antigen presenting cells. Curr Opin Immunol 2011; 23: 111-118.
2. Ma CS, Deenick EK, Batten M, Tangye SG. The origins, function, and regulation of T follicular helper cells. J Exp Med 2012; 209: 1241-1253.
3. Tangye SG, Ma CS, Brink R, Deenick EK. The good, the bad and the ugly - TFH cells in human health and disease. Nat Rev Immunol 2013; 13: 412-426.
4. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000; 192: 1545-1552.
5. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000; 192: 1553-1562.
6. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. In vivoactivated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med 1999; 190: 1123-1134.
7. Haynes NM, Allen CDC, Lesley R, Ansel KM, Killeen N, Cyster JG. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol 2007; 179: 5099-5108.
8. Hardtke S, Ohl L, Förster R. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood 2005; 106: 1924-1931.
9. Morita R, Schmitt N, Bentebibel S-E, Ranganathan R, Bourdery L, Zurawski G et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011; 34: 108-121.
10. Chevalier N, Jarrossay D, Ho E, Avery DT, Ma CS, Yu D et al. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J Immunol 2011; 186: 5556-5568.
11. Rasheed A-U, Rahn H-P, Sallusto F, Lipp M, Müller G. Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur J Immunol 2006; 36: 1892-1903.
12. Simpson N, Gatenby PA, Wilson A, Malik S, Fulcher DA, Tangye SG et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 2009; 62: 234-244.
13. Yu D, Rao S, Tsai LM, Lee SK, He Y, Sutcliffe EL et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009; 31: 457-468.
14. Johnston RJ, Poholek AC, Ditoro D, Yusuf I, Eto D, Barnett B et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009; 325: 1006-1010.
15. Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD et al. Bcl6 mediates the development of T follicular helper cells. Science 2009; 325: 1001-1005.
16. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B et al. BCL-6 protein is expressed in germinal-center B cells. Blood 1995; 86: 45-53.
17. Kitano M, Moriyama S, Ando Y, Hikida M, Mori Y, Kurosaki T et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 2011; 34: 961-972.
18. Ma CS, Avery DT, Chan A, Batten M, Bustamante J, Boisson-Dupuis S et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 2012; 119: 3997-4008.
19. Deenick EK, Chan A, Ma CS, Gatto D, Schwartzberg PL, Brink R et al. Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling. Immunity 2010; 33: 241-253.
20. Bossaller L, Burger J, Draeger R, Grimbacher B, Knoth R, Plebani A et al. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J Immunol 2006; 177: 4927-4932.
21. Liu R, Wu Q, Su D, Che N, Chen H, Geng L et al. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis. Arthritis Res Ther 2012; 14: R255.
22. Ma J, Zhu C, Ma B, Tian J, Baidoo SE, Mao C et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol 2012; 2012: 827480.
23. Pallikkuth S, Parmigiani A, Silva SY, George VK, Fischl M, Pahwa R et al. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood 2012; 120: 985-993.
24. Saito R, Onodera H, Tago H, Suzuki Y, Shimizu M, Matsumura Y et al. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients. J Neuroimmunol 2005; 170: 172-178.
25. Tackenberg B, Kruth J, Bartholomaeus JE, Schlegel K, Oertel WH, Willcox N et al. Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis. Eur. J. Immunol 2007; 37: 849-863.
26. Terrier B, Costedoat-Chalumeau N, Garrido M, Geri G, Rosenzwajg M, Musset L et al. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus. J Rheumatol 2012; 39: 1819-1828.
27. Wang J, Shan Y, Jiang Z, Feng J, Li C, Ma L et al. High frequencies of activated B cells and follicular helper T cells are correlated with disease activity in patients with new onset rheumatoid arthritis. Clin Exp Immunol 2013; 174: 212-220.
28. Hutloff A, Büchner K, Reiter K, Baelde HJ, Odendahl M, Jacobi A et al. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3211-3220.
29. Yang J-H, Zhang J, Cai Q, Zhao D-B, Wang J, Guo P-E et al. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44: 1245-1254.
30. Kawamoto M, Harigai M, Hara M, Kawaguchi Y, Tezuka K, Tanaka M et al. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Arthritis Res Ther 2006; 8: R62.
31. Dolff S, Abdulahad WH, Westra J, Doornbos-van der Meer B, Limburg PC, Kallenberg CG et al. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2011; 13: R157.
32. Rasmussen TK, Andersen T, Hvid M, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K et al. Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol 2010; 37: 2014-2020.
33. Ma CS, Nichols KE, Tangye SG. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu Rev Immunol 2007; 25: 337-379.
34. Ma CS, Hare NJ, Nichols KE, Dupré L, Andolfi G, Roncarolo M-G et al. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J Clin Invest 2005; 115: 1049-1059.
35. Ma CS, Pittaluga S, Avery DT, Hare NJ, Maric I, Klion AD et al. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. J Clin Invest 2006; 116: 322-333.
36. Coraglia A, Felippo M, Schierloh P, Malbran A, de Bracco MM. CD4+ T Lymphocytes with follicular helper phenotype (T(FH)) in patients with SH2D1A deficiency (XLP). Clin Immunol 2011; 141: 357-364.
37. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72: 291-300.
38. Facchetti F, Appiani C, Salvi L, Levy J, Notarangelo LD. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol 1995; 154: 6624-6633.
39. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Dräger R et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4: 261-268.
40. Minegishi Y. Hyper-IgE syndrome. Curr Opin Immunol 2009; 21: 487-492.
41. Avery DT, Deenick EK, Ma CS, Suryani S, Simpson N, Chew GY et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2010; 207: 155-171.
42. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007; 448: 1058-1062.
43. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357: 1608-1619.
44. Ma CS, Suryani S, Avery DT, Chan A, Nanan R, Santner-Nanan B et al. Early commitment of näve human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol Cell Biol 2009; 87: 590-600.
45. Schmitt N, Morita R, Bourdery L, Bentebibel SE, Zurawski SM, Banchereau J et al. Human dendritic cells induce the differentiation of interleukin-21- producing T follicular helper-like cells through interleukin-12. Immunity 2009; 31: 158-169.
46. Ysebrant De Lendonck L, Eddahri F, Delmarcelle Y, Nguyen M, Leo O, Goriely S et al. STAT3 signaling induces the differentiation of human ICOS+ CD4 T cells helping B lymphocytes. PLoS One 2013; 8: e71029.
47. Mazerolles F, Picard C, Kracker S, Fischer A, Durandy A. Blood CD4+CD45RO+ CXCR5+ T cells are decreased but partially functional in signal transducer and activator of transcription 3 deficiency. J Allergy Clin Immunol 2013; 131: 1146-1156, 1156.e1141-1145.
48. Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J et al. Inborn errors of IL-12/23-and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006; 18: 347-361.
49. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280: 1432-1435.
50. de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998; 280: 1435-1438.
51. Schmitt N, Bustamante J, Bourdery L, Bentebibel SE, Boisson-Dupuis S, Hamlin F et al. IL-12 receptor b1 deficiency alters in vivo T follicular helper cell response in humans. Blood 2013; 121: 3375-3385.
52. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9: 235-245.
53. Legac E, Autran B, Merle-Beral H, Katlama C, Debre P. CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood 1992; 79: 1746-1753.
54. Lindqvist M, Van Lunzen J, Soghoian DZ, Kuhl BD, Ranasinghe S, Kranias G et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 2012; 122: 3271-3280.
55. Cubas RA, Mudd JC, Savoye A-L, Perreau M, van Grevenynghe J, Metcalf T et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med 2013; 19: 494-499.
56. Perreau M, Savoye A-L, De Crignis E, Corpataux J-M, Cubas R, Haddad EK et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med 2013; 210: 143-156.
57. Hufert FT, van Lunzen J, Janossy G, Bertram S, Schmitz J, Haller O et al. Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS 1997; 11: 849-857.
58. Mikell I, Sather DN, Kalams SA, Altfeld M, Alter G, Stamatatos L. Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog 2011; 7: e1001251.
59. Pallikkuth S, Pilakka Kanthikeel S, Silva SY, Fischl M, Pahwa R, Pahwa S. Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy. J Immunol 2011; 186: 6173-6181.
60. Locci M, Havenar-Daughton C, Landais E, Wu J, Kroenke MA, Arlehamn CL et al. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 2013.
61. Drachman DB. Myasthenia gravis. N Engl J Med 1994; 330: 1797-1810.
62. Luo C, Li Y, Liu W, Feng H, Wang H, Huang X et al. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. J Neuroimmunol 2013; 256: 55-61.
63. Meraouna A, Cizeron-Clairac G, Panse RL, Bismuth J, Truffault F, Tallaksen C et al. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 2006; 108: 432-440.
64. Shiao Y-M, Lee C-C, Hsu Y-H, Huang S-F, Lin C-Y, Li L-H et al. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia. J Neuroimmunol 2010; 221: 101-106.
65. Weetman AP. Autoimmune thyroid disease. Autoimmunity 2004; 37: 337-340.
66. Zhu C, Ma J, Liu Y, Tong J, Tian J, Chen J et al. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2012; 97: 943-950.
67. Martin N, Li CK, Wedderburn LR. Juvenile dermatomyositis: new insights and new treatment strategies. Ther Advances Musculoskelet Dis 2012; 4: 41-50.
68. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008; 358: 929-939.
69. Feng X, Wang D, Chen J, Lu L, Hua B, Li X et al. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus. PLoS One 2012; 7: e51982.
70. Wong CK, Wong PTY, Tam LS, Li EK, Chen DP, Lam CWK. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol 2010; 30: 45-52.
71. Salomonsson S, Larsson P, Tengné r P, Mellquist E, Hjelmström P, Wahren-Herlenius M. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 2002; 55: 336-342.
72. Li X-Y, Wu Z-B, Ding J, Zheng Z-H, Li X-Y, Chen L-N et al. Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjögren's syndrome. Biochem Biophys Res Commun 2012; 422: 238-244.
73. Szabo K, Papp G, Barath S, Gyimesi E, Szanto A, Zeher M. Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome. Clin Immunol 2013; 147: 95-104.
74. Agrawal S, Misra R, Aggarwal A. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin Rheumatol 2007; 26: 201-204.
75. Chakera A, Bennett SC, Morteau O, Bowness P, Luqmani RA, Cornall RJ. The phenotype of circulating follicular-helper T cells in patients with rheumatoid arthritis defines CD200 as a potential therapeutic target. Clin Dev Immunol 2012; 2012: 948218.
76. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372: 1502-1517.
77. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130: 1089-1104.
78. Christensen JR, Börnsen L, Ratzer R, Piehl F, Khademi M, Olsson T et al. Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17-and activated B-cells and correlates with progression. PLoS ONE 2013; 8: e57820.
79. Tzartos JS, Craner MJ, Friese MA, Jakobsen KB, Newcombe J, Esiri MM et al. IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain. Am J Pathol 2011; 178: 794-802.
80. de Leval L, Rickman DS, Thielen C, Reynies Ad, Huang Y-L, Delsol G et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007; 109: 4952-4963.
81. Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2006; 30: 802-810.
82. Dupuis J, Boye K, Martin N, Copie-Bergman C, Plonquet A, Fabiani B et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006; 30: 490-494.
83. Grogg KL, Attygalle AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A. Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood 2005; 106: 1501-1502.
84. Krenacs L, Schaerli P, Kis G, Bagdi E. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood 2006; 108: 1110-1111.
85. Marafioti T, Paterson JC, Ballabio E, Chott A, Natkunam Y, Rodriguez-Justo M et al. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. Haematologica 2010; 95: 432-439.
86. Morito N, Yoh K, Fujioka Y, Nakano T, Shimohata H, Hashimoto Y et al. Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Cancer Res 2006; 66: 812-819.
87. Roncador G, García Verdes-Montenegro J-F, Tedoldi S, Paterson JC, Klapper W, Ballabio E et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007; 92: 1059-1066.
88. de Leval L, Gisselbrecht C, Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 2010; 148: 673-689.
89. Jaffe ES, Nicolae A, Pittaluga S. Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls. Mod Pathol 2013; 26: S71-S87.
90. Meyerson HJ, Awadallah A, Pavlidakey P, Cooper K, Honda K, Miedler J. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome. Mod Pathol 2012; 26: 32-43.
91. Rodríguez Pinilla SM, Roncador G, Rodríguez-Peralto JL, Mollejo M, García JF, Montes-Moreno S et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 2009; 33: 81-90.
92. Miyoshi H, Sato K, Niino D, Arakawa F, Kimura Y, Kiyasu J et al. Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders. Am J Clin Pathol 2012; 137: 879-889.
93. Gaulard P, De Leval L. Follicular helper T cells: implications in neoplastic hematopathology. Semin Diagn Pathol 2011; 28: 202-213.
94. Ahearne MJ, Willimott S, Piñon L, Kennedy DB, Miall F, Dyer MJS et al. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia. Br J Haematol 2013; 162: 360-370.
95. Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A et al. CD4+ follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest 2013; 123: 2873-2892.